Banys-Paluchowski, M., Loibl, S., Witzel, I., Mundhenke, C., Lederer, B., Solbach, C., . . . Müller, V. (2019). Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG.
Chicago-стиль цитированияBanys-Paluchowski, Malgorzata, et al. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated With Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG, 2019.
MLA-цитированиеBanys-Paluchowski, Malgorzata, et al. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated With Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG, 2019.